We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

65 hedge funds and large institutions have $88.5M invested in Avadel Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.1% less ownership

Funds ownership: 51.4% → 50.31% (-1.1%)

13% less funds holding

Funds holding: 75 → 65 (-10)

30% less capital invested

Capital invested by funds: $126M → $88.5M (-$37.8M)

43% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 23

55% less call options, than puts

Call options by funds: $160K | Put options by funds: $354K

67% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 15

Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
23
Closed
15
Calls
$160K
Puts
$354K
Net Calls
-$194K
Net Calls Change
-$278K

Top Buyers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
+$7.37M
2
Morgan Stanley
Morgan Stanley
New York
+$1.59M
3
BC
Broadfin Capital
New York
+$368K
4
BCM
Brown Capital Management
Maryland
+$277K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$158K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.54M
2
Deutsche Bank
Deutsche Bank
Germany
-$2.04M
3
Millennium Management
Millennium Management
New York
-$2.03M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.14M
5
GCP
GSA Capital Partners
United Kingdom
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
EVM
26
Eaton Vance Management
Massachusetts
$152K – – –
IAMOG
27
Investors Asset Management of Georgia
Georgia
$142K +$47.5K +8,800 +38%
FDCDDQ
28
Federation des caisses Desjardins du Quebec
Quebec, Canada
$127K – – –
Ohio Public Employees Retirement System (OPERS)
29
Ohio Public Employees Retirement System (OPERS)
Ohio
$124K – – –
PCM
30
Palisade Capital Management
New Jersey
$119K +$64.8K +12,000 +80%
Group One Trading
31
Group One Trading
Illinois
$112K +$29.3K +5,433 +27%
State of Tennessee, Department of Treasury
32
State of Tennessee, Department of Treasury
Tennessee
$102K – – –
Goldman Sachs
33
Goldman Sachs
New York
$92K -$89.5K -16,570 -44%
SGAM
34
Smith Group Asset Management
Texas
$92K – – –
CLOS
35
Compagnie Lombard Odier SCmA
Switzerland
$83K – – –
Northern Trust
36
Northern Trust
Illinois
$77K +$11.1K +2,063 +13%
ProShare Advisors
37
ProShare Advisors
Maryland
$75K -$2.61K -484 -3%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$68K – – –
SAM
39
Sectoral Asset Management
Quebec, Canada
$67K +$82.2K +15,218 New
CAM
40
Close Asset Management
United Kingdom
$66K – – –
State of New Jersey Common Pension Fund D
41
State of New Jersey Common Pension Fund D
New Jersey
$62K -$152K -28,074 -67%
PAM
42
Panagora Asset Management
Massachusetts
$57K -$200K -37,116 -74%
QSS
43
Quantitative Systematic Strategies
Florida
$57K -$66.4K -12,296 -49%
US Bancorp
44
US Bancorp
Minnesota
$55K – – –
Bank of America
45
Bank of America
North Carolina
$46K +$32.4K +6,009 +131%
BWP
46
Baldwin Wealth Partners
Massachusetts
$41K – – –
UBS Group
47
UBS Group
Switzerland
$26K +$7.13K +1,321 +28%
EDRH
48
Edmond de Rothschild Holding
Switzerland
$23K – – –
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$22K -$2.87K -532 -10%
JP Morgan Chase
50
JP Morgan Chase
New York
$21K -$708K -131,173 -97%
1
2
3 4

AVDL Hedge Fund Activity: Q3 2018 in Review

65 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q3 2018, worth a combined $88.5M — down 30% from $126M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of AVDL and 5 opened new positions — a net loss of 10 holders — while 23 trimmed existing stakes and 13 added.

The largest buyer was Brandes Investment Partners, adding an estimated $7.37M. The largest seller was Renaissance Technologies, cutting an estimated $2.54M.

  • 65 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q3 2018, down from 75 in Q2 2018.
  • Funds reported $88.5M of Avadel Pharmaceuticals stock for Q3 2018, down 30% quarter-over-quarter.
  • 5 funds opened new Avadel Pharmaceuticals positions in Q3 2018 and 15 closed out, a net change of -10 holders.
  • The largest Avadel Pharmaceuticals buyer in Q3 2018 was Brandes Investment Partners, an estimated $7.37M added.
  • The largest Avadel Pharmaceuticals seller in Q3 2018 was Renaissance Technologies, an estimated $2.54M sold.

Based on aggregated 13F filings for Q3 2018.